NEW BRUNSWICK, NJ—After a state court found the company liable for $572 million in damages for its role in Oklahoma’s opioid crisis, consumer healthcare giant Johnson & Johnson announced Tuesday it would push uppers for the next decade or two in an effort to even everyone out. “We went way too hard on the downers, leaving Americans with highs that made them feel super sleepy and out of it, but now we intend to make things right,” said CEO Alex Gorsky, who pledged his company would aggressively market a new and very powerful line of mephedrone-derived synthetic stimulants to counteract the heavy sedation of opioids. “Don’t worry, this new stuff is gonna set you straight. Doing that much oxy and fentanyl may have been a huge bummer, but if we rush these uppers out the door as fast as we did the painkillers, you’ll be perking up in no time.” Gorsky also assured Johnson & Johnson’s business partners the stimulants it plans to produce will be every bit as addictive as opioids and accompanied by an equally widespread misinformation campaign.
NEW BRUNSWICK, NJ—After a state court found the company liable for $572 million in damages for its role in Oklahoma’s opioid crisis, consumer healthcare giant Johnson & Johnson announced Tuesday it would push uppers for the next decade or two in an effort to even everyone out.
“We went way too hard on the downers, leaving Americans with highs that made them feel super sleepy and out of it, but now we intend to make things right,” said CEO Alex Gorsky, who pledged his company would aggressively market a new and very powerful line of mephedrone-derived synthetic stimulants to counteract the heavy sedation of opioids. “Don’t worry, this new stuff is gonna set you straight.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
The Latest: Oklahoma judge finds J&J fueled opioid crisisNORMAN, Okla. (AP) — The Latest on Oklahoma's opioids case against Johnson & Johnson (all times local): 3:10 p.m. An Oklahoma judge has found Johnson & Johnson and its subsidiaries...
Leer más »
Cramer Remix: Why the Johnson & Johnson fine isn't a tough pill to swallowJim Cramer explains what the Johnson & Johnson ruling means for the stock.
Leer más »
Column: Johnson & Johnson got hit for a $572-million opioid verdict. Why did its stock go up?Here's why Johnson & Johnson's $572-million court judgment looks like good news for investors.
Leer más »
Oklahoma judge to rule in $17 billion opioid lawsuit against J&JAn Oklahoma judge on Monday will decide whether Johnson & Johnson should be held...
Leer más »
J&J liable for $572 million in Oklahoma opioid epidemic trial, but shares surgeOklahoma judge finds Johnson & Johnson liable in opioid epidemic, ordering $572 million damages
Leer más »
Oklahoma judge finds J&J liable in opioid epidemic, orders $572 million damagesAn Oklahoma judge orders Johnson & Johnson to pay $572 million after ruling the drugmaker liable for fueling an opioid epidemic in the state by deceptively marketing painkillers
Leer más »